Status In progress
Process STA
ID number 512

Provisional Schedule

Expected publication 04 October 2017

Project Team

Project lead Stephanie Yates

Email enquiries


Companies sponsors Takeda (brentuximab vedotin)
Others Department of Health
  NHS Blackburn with Darwen CCG
  NHS England
  NHS Wyre Forest CCG
  Welsh Government
Professional groups Association of Cancer Physicians
  Cancer Research UK
  Royal College of Physicians
  Royal College of Radiologists


Comparator companies None
General commentators British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
Relevant research groups Institute of Cancer Research


Key events during the development of the guidance:

Date Update
24 August 2017 - 08 September 2017 Final appraisal determination
12 July 2017 Committee meeting: 2
14 June 2017 - 05 July 2017 Appraisal consultation: 1
16 May 2017 Committee meeting
02 December 2016 Invitation to participate
08 June 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance